Special Drug Use Investigation for ALLERMIST (Long Term)
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2015
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 26 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jul 2014 Planned End Date changed from 1 Feb 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov record.
- 03 Jul 2014 Planned primary completion date changed from 1 Nov 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov record.